Literature DB >> 18459708

Use of selamectin and moxidectin in the treatment of mouse fur mites.

Deborah M Mook1, Kimberly A Benjamin.   

Abstract

A breeding colony consisting of 250 different strains of mice was treated with the topical acaricide selamectin for the mouse fur mite Myocoptes musculinus, with no apparent ill effect, suggesting that this drug is safe for use in mice. To further evaluate their efficacy in treating Myocoptes spp., we compared selamectin with another acaricide, moxidectin, in a controlled manner. Infested mice were treated with selamectin or moxidectin at the time of cage change, and a subset of mice was retreated 10 d later. Mice underwent routine cellophane tape examination of the pelage for 1 y. Although no adult mites were found in any group at 1 mo after treatment, egg casings were found in the selamectin treatment group as late as 6 mo after treatment, prompting concern about its effectiveness. Moxidectin used in combination with cage changing was effective in eradicating mites, with mice negative for traces of mites on cellophane tape examination of the pelage from months 2 through 12 after treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18459708      PMCID: PMC2654009     

Source DB:  PubMed          Journal:  J Am Assoc Lab Anim Sci        ISSN: 1559-6109            Impact factor:   1.232


  29 in total

1.  Comparative speed of kill of selamectin, imidacloprid, and fipronil-(S)-methoprene spot-on formulations against fleas on cats.

Authors:  M W Dryden; V Smith; P A Payne; T L McTier
Journal:  Vet Ther       Date:  2005

Review 2.  Preventing parasites in cats.

Authors:  Michael W Dryden; Patricia A Payne
Journal:  Vet Ther       Date:  2005

3.  Murine acariasis. II. Immunological dysfunction and evidence for chronic activation of Th-2 lymphocytes.

Authors:  P Jungmann; A Freitas; A Bandeira; A Nobrega; A Coutinho; M A Marcos; P Minoprio
Journal:  Scand J Immunol       Date:  1996-06       Impact factor: 3.487

4.  Cross-fostering in combination with ivermectin therapy: a method to eradicate murine fur mites.

Authors:  Michael J Huerkamp; Lois A Zitzow; Sonji Webb; Jennifer K Pullium
Journal:  Contemp Top Lab Anim Sci       Date:  2005-07

5.  Induction of IgE and allergic-type responses in fur mite-infested mice.

Authors:  Veronika Pochanke; Sarah Hatak; Hans Hengartner; Rolf M Zinkernagel; Kathy D McCoy
Journal:  Eur J Immunol       Date:  2006-09       Impact factor: 5.532

6.  Efficacy and safety of selamectin against Sarcoptes scabiei on dogs and Otodectes cynotis on dogs and cats presented as veterinary patients.

Authors:  R H Six; R G Clemence; C A Thomas; S Behan; M G Boy; P Watson; H A Benchaoui; P J Clements; T G Rowan; A D Jernigan
Journal:  Vet Parasitol       Date:  2000-08-23       Impact factor: 2.738

7.  Efficacy of selamectin administered topically in the treatment of feline otoacariosis.

Authors:  C Blot; A Kodjo; M-C Reynaud; G Bourdoiseau
Journal:  Vet Parasitol       Date:  2003-03-10       Impact factor: 2.738

8.  Pharmacokinetics of selamectin in dogs after topical application.

Authors:  J Dupuy; A L Derlon; J F Sutra; M C Cadiergues; M Franc; M Alvinerie
Journal:  Vet Res Commun       Date:  2004-07       Impact factor: 2.459

9.  Murine acariasis: I. Pathological and clinical evidence suggesting cutaneous allergy and wasting syndrome in BALB/c mouse.

Authors:  P Jungmann; J L Guénet; P A Cazenave; A Coutinho; M Huerre
Journal:  Res Immunol       Date:  1996-01

10.  Risks of Infection among Laboratory Rats and Mice at Major Biomedical Research Institutions.

Authors:  Robert O. Jacoby; J. Russell Lindsey
Journal:  ILAR J       Date:  1998
View more
  13 in total

1.  Assessment of immune activation in mice before and after eradication of mite infestation.

Authors:  Nancy A Johnston; Rita A Trammell; Susan Ball-Kell; Steven Verhulst; Linda A Toth
Journal:  J Am Assoc Lab Anim Sci       Date:  2009-07       Impact factor: 1.232

2.  The rodent quarantine quagmire.

Authors:  Deborah Mook; Douglas K Taylor; Michael J Huerkamp
Journal:  J Am Assoc Lab Anim Sci       Date:  2009-09       Impact factor: 1.232

3.  Comparison of a fur mite PCR assay and the tape test for initial and posttreatment diagnosis during a natural infection.

Authors:  Erica E Weiss; Kristin D Evans; Stephen M Griffey
Journal:  J Am Assoc Lab Anim Sci       Date:  2012       Impact factor: 1.232

4.  Combined evaluation of commonly used techniques, including PCR, for diagnosis of mouse fur mites.

Authors:  Eleanor M Karlsson; Laura M Pearson; Kristen M Kuzma; Tanya H Burkholder
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-01       Impact factor: 1.232

5.  Effect of sampling strategy on the detection of fur mites within a naturally infested colony of mice (Mus musculus).

Authors:  Kelly A Metcalf Pate; Kelly A Rice; Roberta Wrighten; Julie Watson
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-05       Impact factor: 1.232

6.  Effects of Fenbendazole-impregnated Feed and Topical Moxidectin during Quarantine on the Gut Microbiota of C57BL/6 Mice.

Authors:  Scott W Korte; Craig L Franklin; Rebecca A Dorfmeyer; Aaron C Ericsson
Journal:  J Am Assoc Lab Anim Sci       Date:  2018-05-01       Impact factor: 1.232

7.  Treatment and eradication of murine fur mites: II. Diagnostic considerations.

Authors:  Rodolfo J Ricart Arbona; Neil S Lipman; Felix R Wolf
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-09       Impact factor: 1.232

8.  Treatment and eradication of murine fur mites: I. Toxicologic evaluation of ivermectin-compounded feed.

Authors:  Rodolfo J Ricart Arbona; Neil S Lipman; Elyn R Riedel; Felix R Wolf
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-09       Impact factor: 1.232

9.  Treatment and eradication of murine fur mites: III. Treatment of a large mouse colony with ivermectin-compounded feed.

Authors:  Rodolfo J Ricart Arbona; Neil S Lipman; Felix R Wolf
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-09       Impact factor: 1.232

10.  Moxidectin toxicity in senescence-accelerated prone and resistant mice.

Authors:  Vanessa K Lee; Asheesh K Tiwary; Prachi Sharma-Reddy; Karen A Lieber; Douglas K Taylor; Deborah M Mook
Journal:  Comp Med       Date:  2009-06       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.